BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24552858)

  • 1. The prevalence of nonalcoholic fatty liver disease in the Americas.
    López-Velázquez JA; Silva-Vidal KV; Ponciano-Rodríguez G; Chávez-Tapia NC; Arrese M; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2014; 13(2):166-78. PubMed ID: 24552858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.
    Sayiner M; Koenig A; Henry L; Younossi ZM
    Clin Liver Dis; 2016 May; 20(2):205-14. PubMed ID: 27063264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
    Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and nonalcoholic fatty liver disease.
    Angulo P
    Nutr Rev; 2007 Jun; 65(6 Pt 2):S57-63. PubMed ID: 17605315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-alcoholic fatty liver disease in type 2 diabetes: pathogenesis and treatment options.
    Tziomalos K; Athyros VG; Karagiannis A
    Curr Vasc Pharmacol; 2012 Mar; 10(2):162-72. PubMed ID: 22239625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology, pathogenesis and histopathology of fatty liver disease.
    Levene AP; Goldin RD
    Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in Asia: emerging perspectives.
    Seto WK; Yuen MF
    J Gastroenterol; 2017 Feb; 52(2):164-174. PubMed ID: 27637587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global incidence and prevalence of nonalcoholic fatty liver disease.
    Teng ML; Ng CH; Huang DQ; Chan KE; Tan DJ; Lim WH; Yang JD; Tan E; Muthiah MD
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S32-S42. PubMed ID: 36517002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome.
    Dietrich P; Hellerbrand C
    Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):637-53. PubMed ID: 25194181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GI epidemiology: nonalcoholic fatty liver disease.
    Angulo P
    Aliment Pharmacol Ther; 2007 Apr; 25(8):883-9. PubMed ID: 17402991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The obesity epidemic and nonalcoholic fatty liver disease in children.
    Dunn W; Schwimmer JB
    Curr Gastroenterol Rep; 2008 Feb; 10(1):67-72. PubMed ID: 18417045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
    Vernon G; Baranova A; Younossi ZM
    Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.